These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14967602)

  • 1. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
    Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
    Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
    Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
    Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
    Lundgren J; Kylhammar D; Hedelin P; Rådegran G
    Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
    Geiger R; Pajk W; Neu N; Maier S; Kleinsasser A; Fratz S; Navarro-Psiha S; Fischer V; Treml B; Loeckinger A
    Pediatr Res; 2006 Jan; 59(1):147-50. PubMed ID: 16327003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
    Persson BP; Rossi P; Weitzberg E; Oldner A
    Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
    Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
    Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
    Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
    Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
    Lourenço AP; Vasques-Nóvoa F; Oliveira-Pinto J; Fontoura D; Roncon-Albuquerque R; Leite-Moreira AF
    Intensive Care Med; 2012 Jun; 38(6):1050-60. PubMed ID: 22349420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange.
    Rossi P; Wanecek M; Konrad D; Oldner A
    Shock; 2004 Jun; 21(6):543-8. PubMed ID: 15167683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tezosentan, a non-selective endothelin receptor antagonist, on shear stress-induced changes in arterial diameter of the anaesthetized dog.
    Markos F; Hennessy BA; Fitzpatrick M; O'Sullivan J; Snow HM
    J Physiol; 2002 Nov; 544(3):913-8. PubMed ID: 12411533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension.
    Geiger R; Treml B; Kleinsasser A; Neu N; Fischer V; Stein JI; Loeckinger A
    High Alt Med Biol; 2008; 9(3):223-7. PubMed ID: 18800959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas.
    Wang J; Oldner A; Winskog C; Edston E; Walther SM
    Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tezosentan, another selective selection for pulmonary hypertension, or not?
    Lorts A; Shanley TP
    Pediatr Crit Care Med; 2004 Nov; 5(6):586-8. PubMed ID: 15540040
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs.
    Romand JA; Pinsky MR; Firestone L; Zar HA; Lancaster JR
    J Appl Physiol (1985); 1994 Mar; 76(3):1356-62. PubMed ID: 7911801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.
    Walweel K; Skeggs K; Boon AC; See Hoe LE; Bouquet M; Obonyo NG; Pedersen SE; Diab SD; Passmore MR; Hyslop K; Wood ES; Reid J; Colombo SM; Bartnikowski NJ; Wells MA; Black D; Pimenta LP; Stevenson AK; Bisht K; Marshall L; Prabhu DA; James L; Platts DG; Macdonald PS; McGiffin DC; Suen JY; Fraser JF
    J Biomed Sci; 2020 Oct; 27(1):96. PubMed ID: 33008372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.